cell-based assay (cba (EUROIMMUN)
90
Structured Review
EUROIMMUN
cell-based assay (cba
Cell Based Assay (Cba, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell-based+assay+(cba/cell+based+assay/nct06388161-5-2-4
Average 90 stars, based on 1 article reviews
Cell Based Assay (Cba, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell-based+assay+(cba/cell+based+assay/nct06388161-5-2-4
Average 90 stars, based on 1 article reviews
cell-based assay (cba - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Cell Based Assay:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Crocin Bleaching Assay:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Clinical Proteomics:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Staining:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Cell Counting:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Diagnostic Assay:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Magnetic Resonance Imaging:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a Activity Assay:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a RIA Assay:Article Title: Clinical characteristics and prognosis in patients with neuronal surface antibody-mediated autoimmune encephalitis: a single-center cohort study in China Article Snippet: In reference to the diagnostic criteria suggested by Graus et al. in 2016 ( ) and Chinese expert consensus of AE (2017 edition) , patients were included in this study based on the following criteria: (1) acute or subacute onset (<3 months) of one or more of the following symptoms: a. symptoms of the limbic system: psychiatric symptoms, memory deficit, seizure; b. encephalitis syndrome: clinical manifestations of diffuse or multifocal brain damage; c. clinical manifestations of basal ganglia and/or diencephalon/hypothalamus involvement; d. psychiatric disorder that does not qualify as a non-organic disease by a psychologist; (2) with or without CSF (cerebrospinal fluid) pleocytosis, magnetic resonance imaging (MRI) features of encephalitis, or electroencephalogram (EEG) with epileptic or slow-wave activity; (3) CSF and blood serum antibody testing positive for anti-NMDAR antibodies based on a cell-based assay (CBA)( Article Title: CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study. Article Snippet: Antibody positivity was reported qualitatively as weakly (+), moderately (++) and strongly positive (+++) and based on a commercial Article Title: Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges Article Snippet: A standard commercial cell-based assay (CBA, Article Title: Mortality of neuromyelitis optica spectrum disorders in a Chinese population Article Snippet: We collected the following information and entered it into our NMOSD database: demographics, age at onset, disease duration, phenotype at onset, number of relapses, time to the second attack, number of severe attacks, annualized relapse rate (ARR, the number of attacks per patient‐year), AQP4‐Ab, and Article Title: The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy Article Snippet: A radioimmunoassay (RIA) (RSR Ltd., Cardiff, Wales, United Kingdom) and Article Title: Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy Article Snippet: Antibodies were detected in serum and/or in CSF using commercial Article Title: Case Report: Overlapping Syndrome of Anti-NMDAR Encephalitis and MOG Inflammatory Demyelinating Disease in a Patient With Human Herpesviruses 7 Infection Article Snippet: Upon search for anti-neural antibodies (to anti-NMDAR, anti-LGI1, anti-CASPR2, anti-AMPAR, anti-GABABR, anti-DPPX, and anti-mGLuR5), Article Title: Case report: Isolated brainstem-cerebellar symptoms in a patient with anti-NMDA receptor encephalitis Article Snippet: Additionally, the presence of a |